Diffuse Large B-Cell Lymphoma Arising from Cauda Equina: A Rare Case Report and Review of the Literature
Open Access
Abstract
Background: Malignant lymphoma is the most common hematological malignancy; however, primary central nervous system lymphoma accounts for only a small percentage of non-Hodgkin lymphoma (NHL). Among these, primary cauda equina lymphoma (CEL) is extremely uncommon. Its rarity and atypical clinical presentation often make diagnosis challenging. Case Presentation: An 80-year-old man presented with progressive gait disturbance, lower-extremity weakness, and numbness. MRI revealed diffuse swelling and homogeneous gadolinium enhancement of the cauda equina at T12–L1; additionally, CSF cytology identified malignant lymphocytes. Open biopsy confirmed a diagnosis of diffuse large B-cell lymphoma. At diagnosis, the patient was classified as Ann Arbor stage IV, and the clinical parameters corresponded to a high-risk International Prognostic Index (IPI) category. The patient received five courses of immunochemotherapy with rituximab, methotrexate, vincristine, and procarbazine (R-MPV), resulting in marked radiological improvement and functional recovery, achieving a complete response. However, consolidation therapy was discontinued as the patient did not wish to continue. Unfortunately, intracranial relapse occurred four months later, and the patient ultimately succumbed to infectious complications. Only 29 cases of primary CEL have been reported. For all cases, a biopsy with histopathological examination is required for a definitive diagnosis. Currently, combined chemotherapy and radiotherapy are considered the standard treatment. This case was diagnosed through nerve biopsy with cauda equina at T12 to L1 levels, and immunochemotherapy successfully reduced the lesion while improving lower extremity function. Conclusions: Despite the considerable burden on patients, nerve biopsy is necessary for primary CEL to obtain a diagnosis and an early therapeutic approach for both neurological and vital prognoses.Keywords
This publication has 36 references indexed in Scilit:
- JSH practical guidelines for hematological malignancies, 2023: II. lymphoma—overviewInternational Journal of Hematology, 2025
- Primary Cauda Equina T-Cell Lymphoblastic LymphomaWorld Neurosurgery, 2020
- Primary lymphoma involving cranial nerves and cauda equina detected by 18F-FDG PET/CT and MRINuklearmedizin-Nuclear Medicine, 2016
- Cauda equina syndrome due to large B-cell lymphoma: a case reportNeurological Sciences, 2016
- Primary B-cell lymphoma of the cauda equina, successfully treated with high-dose methotrexate plus high-dose cytarabine: a case report with MRI findingsNeurological Sciences, 2011
- Primary leptomeningeal lymphoma of the cauda equina: a rare cause of radiculopathyJournal of Neurology, 2010
- Hypertrophy of the Nerve Roots of the Cauda Equina as a Paraneoplastic Manifestation of LymphomaArchives of Neurology, 2005
- Non-Hodgkin's lymphoma involving the cauda equina and ocular cranial nerves: case reports and literature reviewJournal of Clinical Neuroscience, 2003
- Primary EBV-associated cauda equina lymphoma.Journal of Neurology, 1999
- Primary CNS Lymphoma: Lymphomatous Meningitis Presenting as a Cauda Equina Lesion in an AIDS PatientCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1990